INNOCAN PHARMA Corp
INNPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,008 | $3,885 | $4,947 | $11,048 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $686 | $249 | $243 | $0 |
| Inventory | $3,317 | $1,738 | $1,131 | $510 |
| Other Curr. Assets | $136 | $921 | $738 | $963 |
| Total Curr. Assets | $9,147 | $6,804 | $6,878 | $12,521 |
| Property Plant & Equip (Net) | $113 | $136 | $98 | $54 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$98 | -$54 |
| Total NC Assets | $113 | $136 | $98 | $54 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9,260 | $6,940 | $6,976 | $12,575 |
| Liabilities | – | – | – | – |
| Payables | $185 | $111 | $95 | $53 |
| Short-Term Debt | $10 | $22 | $14 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $318 | $432 |
| Other Curr. Liab. | $2,043 | $2,410 | $622 | $3,510 |
| Total Curr. Liab. | $2,238 | $2,543 | $731 | $3,564 |
| LT Debt | $0 | $11 | $20 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $11 | $20 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $10 | $33 | $34 | $1 |
| Total Liabilities | $2,238 | $2,554 | $751 | $3,564 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$34,908 | -$33,074 | -$28,374 | -$24,610 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $40,075 | $37,177 | $34,768 | $33,665 |
| Total Equity | $5,167 | $4,103 | $6,394 | $9,055 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,855 | $283 | -$169 | -$44 |
| Total Liab. & Tot. Equity | $9,260 | $6,940 | $6,976 | $12,575 |
| Net Debt | -$4,998 | -$3,852 | -$4,913 | -$11,047 |